Yanlong Li - Concepedia

Author

Yanlong Li

Also Known As

Ding-Quan Qian, Li, Yanlong, Y. M. Li, Y. X. Wang, Y.- M. Li, Y.M. Li, Yan-Long Li, Yan-long LI, Yan-long Li, Yang-You Li

173

Publications

4.9K

Citations

H-Index

123

Concepts

All Affiliations

Incyte (United States)Huazhong Agricultural University Ningxia Academy of Agriculture and Forestry Sciences Xinjiang Academy of Agricultural Sciences Experimental Station

About

Yanlong Li is an author at Incyte (United States) specializing in medicine, pharmacology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	4	4	158
2	Health Sciences	2	2	70
3	Business	1	1	31
4	Education	1	1	54
5	Law	1	1	31

Yanlong Li

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms Alfonso Quintás‐Cardama, Kris Vaddi, Phillip Liu, Blood	2010	813
Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity Xiangdong Liu, Niu Shin, Holly K. Koblish, Blood	2010	552
Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050 Jordan S. Fridman, Peggy Scherle, Robert J. Collins, The Journal of Immunology ImmunologyKinase InhibitorsImmunotherapyMusculoskeletal ResearchInflammatory Arthritis	2010	440
Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer Bin-Bing Zhou, Michael Peyton, Biao He, Cancer Cell Tumor BiologyAdam-mediated Ligand CleavageEgfr PathwaysMedicineBronchial Neoplasm	2006	375
INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology Eddy W. Yue, Richard Sparks, Padmaja Polam, ACS Medicinal Chemistry Letters	2017	290
Discovery of Potent Competitive Inhibitors of Indoleamine 2,3-Dioxygenase with in Vivo Pharmacodynamic Activity and Efficacy in a Mouse Melanoma Model Eddy W. Yue, Brent Douty, Brian Wayland, Journal of Medicinal Chemistry PharmacotherapyVivo Pharmacodynamic ActivityPharmaceutical ChemistryTumor BiologyMedicinal Chemistry	2009	216
Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells Phillip C.C. Liu, Xiangdong Liu, Yanlong Li, Cancer Biology & Therapy Erbb Family MembersBreast OncologyMolecular BiologyMajor SourceMolecular Research	2006	184
Structure-Based Design and Discovery of Protein Tyrosine Phosphatase Inhibitors Incorporating Novel Isothiazolidinone Heterocyclic Phosphotyrosine Mimetics Andrew P. Combs, Eddy W. Yue, Michael J. Bower, Journal of Medicinal Chemistry Molecular DockingCrystal StructureMedicinal ChemistryCombinatorial ChemistryBiochemistry	2005	101
Potent Benzimidazole Sulfonamide Protein Tyrosine Phosphatase 1B Inhibitors Containing the Heterocyclic ( <i>S</i> )-Isothiazolidinone Phosphotyrosine Mimetic Andrew P. Combs, Wenyu Zhu, Matthew L. Crawley, Journal of Medicinal Chemistry	2006	85
Enhancement of nutrient resorption efficiency increases plant production and helps maintain soil nutrients under summer grazing in a semi-arid steppe Tongrui Zhang, Frank Yonghong Li, Chunjun Shi, Agriculture Ecosystems & Environment BiogeochemistrySummer GrazingEngineeringPlant-soil InteractionPlant-soil Relationship	2020	75

Page 1